Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-1897
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-1897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 02)
This is a report on a combination of placebo-controlled trials involving Diltiazem hydrochloride extended-release capsules for angina and hypertension. The report includes a comparison of the adverse reactions between Diltiazem hydrochloride and the placebo, with percentages provided for each reaction category. Adverse reactions for Diltiazem hydrochloride include headache, dizziness, bradycardia, AV block, edema, and asthenia. The severity and duration of these adverse reactions are not specified.*
Label (Lbl713351897)
This appears to be a medication label for DilTIAzem Hcl, a blue capsule with a strength of 360mg. The label includes instructions to store the medication at room temperature (between 20-25°C/68-77°F) and to keep it out of reach of children. The medication comes in a bottle of 30 capsules, with an expiration date of MM/YY not specified. The NDC code specific to this particular medication is 7133518971 07981301523487.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
